Bone marrow transplantation in Italy — get 3 personalized clinic matches

A bone marrow transplant in Italy is not considered major open surgery but rather a specialized cellular therapy. The procedure involves infusing healthy stem cells intravenously through a central venous catheter, similar to a blood transfusion, without requiring surgical incisions or operating room intervention.

• Administration method: Stem cells enter the bloodstream via a central venous catheter or PICC line.
• Surgical classification: Italian medical systems categorize this as specialized hematological treatment, not a surgical operation.
• Donor harvesting: Marrow collection uses minor needle aspirations under anesthesia, not large surgical incisions.
• Conditioning phase: Patients undergo high-dose chemotherapy or radiation before infusion to prepare the body.

Bookimed Expert Insight: Italian centers like San Raffaele demonstrate high technical proficiency, having completed over 1,000 bone marrow transplants. Data shows that while the infusion is non-surgical, the complexity lies in the conditioning phase. Choosing clinics with IRCCS accreditation ensures access to research-driven protocols that often include advanced haploidentical transplantation techniques.

Patient Consensus: The term transplant can be misleading as the actual process feels more like a long infusion. Most emphasize that the conditioning phase and strict isolation period are the most demanding parts of the journey.

Hospital stay after bone marrow transplantation in Italy typically lasts 3 to 6 weeks. Discharge is contingent on blood count stability, specifically neutrophils and platelets, rather than a fixed date. Patients then undergo 100 days of restricted living nearby to monitor for infections or graft-versus-host disease.

• Inpatient duration: Patients stay 3–6 weeks for conditioning, cell infusion, and the critical engraftment phase.
• Discharge criteria: Doctors require stable blood counts and no active complications before allowing hospital departure.
• Restricted living: Post-discharge recovery requires staying near the center for 100 days with frequent monitoring.
• Immune reconstitution: Full recovery of energy, fitness, and immune function takes 6 to 18 months.

Bookimed Expert Insight: Milan has become a primary hub for hematology because clinics like San Raffaele have completed over 1,000 transplants. Dr. Jacopo Peccatori alone performs about 90 allogeneic transplants annually. This concentration of expertise is why Italian centers often handle complex haploidentical cases that other regions might decline.

Patient Consensus: Patients emphasize that discharge depends entirely on how fast blood counts stabilize. Many advise securing local housing and a dedicated caregiver well before the 3-week mark to ensure a smooth transition from the hospital.

Prominent Italian medical institutions for bone marrow transplants include IRCCS Ospedale San Raffaele, Policlinico San Martino, and Sant'Orsola. These centers provide autologous and allogeneic procedures within the Italian Group for Bone Marrow Transplantation (GITMO) network. They specialize in treating acute leukemias and complex immune deficiencies.

• San Raffaele Milan: Performed over 1,000 transplants and pioneered the world's first genetic stem cell therapy.
• Sant'Orsola Bologna: Operates as a national reference center for large-volume hematology and complex blood disorders.
• San Martino Genoa: Serves as a major oncology hub integrated into international marrow donor registries.
• Gemelli Policlinico Rome: Features advanced cell-processing laboratories for high-volume teaching and research-based transplantation.

Bookimed Expert Insight: San Raffaele stands out because its lead specialists, like Dr. Jacopo Peccatori, perform about 90 allogeneic transplants annually. While many centers offer autologous options, this specific volume for donor-based procedures indicates a very high level of technical proficiency and registry coordination.

Patient Consensus: Finding a dedicated stem cell unit is more important than choosing a general hospital. Logistics regarding donor matching and the lengthy inpatient stay for infection precautions are the most critical factors to plan for.